Research and Markets: Assessment of the Molecular Diagnostic Market for 44 NA Tests in Italy

* Reuters is not responsible for the content in this press release.

Thu Oct 29, 2009 12:44pm EDT

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/427def/assessment_of_the) has
announced the addition of the "Assessment of the Molecular Diagnostic Market for
44 NA Tests in Italy" report to their offering. 

Hospital and private laboratories have been surveyed to collect information on
NA tests performed, test volumes and used platforms and reagents. For data
reliability and accurate projections at segment level a 3 step methodology has
been applied:

* Step 1: Identification of the total number of laboratories by secondary
research and short telephone interviews with 732 hospitals to verify existence
of internal laboratories. 
* Step 2: 932 laboratories in Italy were classified for NAT activity and overall
NA test volume. 
* Step 3: 73 laboratories provided data on NA test volume, kits, platforms and
trends. A list of 44 NA tests have been provided to the labs for structured data
entry. All data has been analysed and projected at total market level. Data is
available by test and country.

Executive Summary 

dii is an international marketing consulting company entirely specialised in
healthcare markets providing market information and support to strategic market
decisions. In cooperation with key industry a Continuous European Molecular
Market Assessment has been realized in 2009 with the 2 main objectives:

* 1) Classification of laboratories by ownership, size and overall NA test
volume 
* 2) Market assessment for 44 NA tests on volumes, trends, kits and analyzers.
All data is presented in Excel and PPT. Excel addresses all quantitative
questions at segment level, including all volume projection scenarios and
statistical detail, PPT presents the key data and provides an interpretation of
general business implications

Key Topics Covered:

* Total number of clinical diagnostic labs by segment 
* Number of clinical diagnostic NA labs by segment 
* # of lab performing test by test type 
* Total # of test/results per test type & growth rate 
* Market share: # of tests/results by supplier 
* Installed base of analyzers 
* Trends

Companies Mentioned:

* Roche Diagnostics 
* Innogenetics 
* Abbott 
* Bio-Rad 
* bioMérieux 
* Applied Biosystems 
* Siemens 
* Nanogen 
* Chiron

For more information visit
http://www.researchandmarkets.com/research/427def/assessment_of_the

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716 

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.